Difficulty: Medium
Average Score: 72%
Practice
A hospital patient's complex medical history includes a recent diagnosis of kidney cancer. Which of the following medications is used to treat metastatic kidney cancer?
Correct answer
B
Rationale
Aldesleukin, a recombinant interleukin-2, treats metastatic kidney cancer by activating cellular immunity, particularly T-cells, to target cancer cells, offering a survival benefit despite pulmonary risks. Filgrastim aids neutropenia, interferon alfa-2b suits leukemia, and darbepoetin alfa corrects anemia none directly address kidney cancer. Aldesleukin's immunostimulatory action fits this diagnosis, leveraging the immune system against metastatic spread, a key therapeutic strategy in renal carcinoma management.